Is GERN Worth Buying in 2026?

Geron Corp

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-08-23

Here’s whether Geron Corp (GERN) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.

🟢
Bullish

Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+5.43% over 10 days); RSI 62 — healthy momentum range; 3-month momentum positive (+18.8%). Concerns: declining volume on rally — weak conviction (0.79x 30d avg). Currently 24.4% off its 52-week high. Score: +5/7.

Ready to act on this? 📈 Trade on Webull

GERN is in a confirmed uptrend, trading above both its 50-day ($1.41) and 200-day ($1.42) moving averages. An RSI of 62.0 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +6.3% compares to +20.5% for SPY (trailed the market by 14.2%). The current 24.4% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $10,629 today
vs. S&P 500 (SPY) — same period trailed market by 14.2%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($1.42)
Above 50-day MA ($1.41)
RSI(14) neutral zone (30–70) — currently 62.0
Positive return (+6.3%)
!Within 10% of period high (−24.4%)
Period Range $1.52
$1.04 $2.01
RSI (14) 62.0
0 · OversoldOverbought · 100

Key Metrics

Price$1.52
Period Return+6.3%
Period High$2.01
Period Low$1.04
Drawdown−24.4%
MA-50$1.41
MA-200$1.42
RSI (14)62.0
Avg Volume (30d)9.6M
vs. SPYtrailed by 14.2%
Return Rank#510 of 999

Trade GERN

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers